The "stroke market" pertains to the healthcare sector's focus on preventing, diagnosing, and treating strokes, a leading cause of disability and death worldwide. Its features encompass a wide range of medical devices, pharmaceuticals, and therapeutic interventions designed to improve patient outcomes. The benefits of a robust stroke market include enhanced patient care, reduced healthcare costs, and extended life expectancy. Its applications span from advanced neuroimaging technologies for early detection to innovative pharmaceuticals targeting stroke risk factors
According to Data Bridge Market Research, the Global Stroke Market which was USD 31,000.00 million in 2022, is expected to reach USD 57,378.84 million by 2030 and is expected to undergo a CAGR of 8.0% during the forecast period of 2023-2030.
“Increasing Awareness and Government Initiatives Drive the Market Growth"
The stroke market is witnessing substantial growth due to increasing awareness and government initiatives. Efforts to educate the public about stroke risk factors, symptoms, and preventive measures have raised awareness significantly. Governments are implementing programs to enhance stroke care and rehabilitation, further driving market expansion. The availability of untapped markets, a large population base, and a growing demand for quality healthcare services have collectively propelled the stroke market, offering hope for improved stroke prevention, treatment, and patient outcomes.
What restraints the growth of the global stroke market?
“Limited treatment options for hemorrhagic strokes limits the market growth rate."
The stroke market faces a notable restraint in the form of limited treatment options for hemorrhagic strokes, a condition characterized by bleeding in the brain. Traditional treatments like surgery and medication have had mixed success in addressing this complex ailment, which has led to the pressing need for more effective interventions. Hemorrhagic strokes pose a significant clinical challenge due to their life-threatening nature and often unpredictable outcomes.
Segmentation: Global Stroke Market
The stroke market is segmented on the basis of type, diagnostic type, treatment type, therapeutic type, end type, route of administration, and mode of purchase.
- On the basis of type, the stroke market is segmented into ischemic, hemorrhagic, transient ischemic attack (TIA), and others.
- On the basis of diagnostic type, the stroke market is segmented into magnetic resonance imaging (MRI), computed tomography scan (CT scan), cerebral angiography, and others.
- On the basis of treatment type, the stroke market is segmented into anti-coagulant and anti-platelets.
- On the basis of therapeutic type, the stroke market is segmented into stent retriever, surgical clipping, embolic coils, aspir.ation catheters others.
- On the basis of end type, the stroke market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, others.
- On the basis of route of administration, the stroke market is segmented into oral, parenteral, and intravenous.
- On the basis of mode of purchase, the stroke market is segmented into prescription, retail, and over the counter.
Regional Insights: North America is expected to dominate the Global Stroke Market
North America's leading position in the stroke market can be attributed to its well-established healthcare infrastructure, the prominent presence of major industry players, a growing prevalence of life-threatening illnesses, and an increasing volume of research initiatives within the region.
Asia-Pacific is expected to witness significant growth because of the surge in government-sponsored initiatives to raise awareness, the flourishing medical tourism sector, expanding research endeavors, untapped market potential, a substantial population base, and an escalating demand for high-quality healthcare services are all contributing factors to the region's grow
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/global-stroke-market
Recent Developments in the Global Stroke Market
- In May 2021, Siemens revealed the Somatom X.ceed1, a new high-resolution, high-speed CT (computed tomography) scanner designed exclusively for the most difficult clinical sectors.
- In April 2021, In order to jointly market its digital pathology and artificial intelligence (AI) solutions to hospitals, health networks, and pathology labs around the world, Koninklijke Philips N.V. announced its strategic alliance with Ibex Medical Analytics.
The Prominent Key Players Operating in the Global Stroke Market Include:
- Novartis AG (Switzerland)
- Endo International Inc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Cipla Inc (India)
- Dr Reddy's Laboratories Ltd (India)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc (U.S.)
- Zydus Group (India)
- Lupin (India)
- Amorphex Therapeutics Holdings, Inc (U.S.)
- Bausch Health Companies Inc. (Canada)
- Cardinal Health (U.S)
- Genentech, Inc. (U.S.)
- Medtronic (Ireland)
- GENERAL ELECTRIC (U.S.)
- Stryker (U.S.)
- Merck & Co., Inc. (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Hitachi Medical Systems (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of global stroke market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Stroke Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
